Screening par chromatographie liquide couplée à la spectrométrie de masse (LC-MS) = Screening by liquid chromatography coupled with mass spectromety (LC-MS)MAURER, Hans H.Annales de toxicologie analytique. 2005, Vol 17, Num 1, pp 13-20, issn 0768-598X, 8 p.Conference Paper

How Can Analytical Diagnostics in Clinical Toxicology Be Successfully Performed Today?MAURER, Hans H.Therapeutic drug monitoring. 2012, Vol 34, Num 5, pp 561-564, issn 0163-4356, 4 p.Article

Mass spectrometric approaches in impaired driving toxicologyMAURER, Hans H.Analytical & bioanalytical chemistry (Print). 2009, Vol 393, Num 1, pp 97-107, issn 1618-2642, 11 p.Article

Hyphenated mass spectrometric techniques : indispensable tools in clinical and forensic toxicology and in doping controlMAURER, Hans H.Journal of mass spectrometry. 2006, Vol 41, Num 11, pp 1399-1413, issn 1076-5174, 15 p.Article

Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluidMAURER, Hans H.Analytical and bioanalytical chemistry. 2005, Vol 381, Num 1, pp 110-118, 9 p.Article

Chemistry, Pharmacology, and Metabolism of Emerging Drugs of AbuseMAURER, Hans H.Therapeutic drug monitoring. 2010, Vol 32, Num 5, pp 544-549, issn 0163-4356, 6 p.Article

Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology : Analytical toxicologyMAURER, Hans H.Analytical and bioanalytical chemistry. 2007, Vol 388, Num 7, pp 1315-1325, 11 p.Article

Chromatography and capillary electrophoresis in forensic and clinical toxicologyMAURER, Hans H.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 713, Num 1, issn 1387-2273, 282 p.Serial Issue

Perspectives of Liquid Chromatography Coupled to Low-and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic ToxicologyMAURER, Hans H.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 324-327, issn 0163-4356, 4 p.Conference Paper

LC-MS et LC-MS/MS en toxicologie analytique = LC-MS and LC-MS/MS in analytical toxicologyMAURER, Hans H.Annales de toxicologie analytique. 2005, Vol 17, Num 1, issn 0768-598X, 70 p.Conference Proceedings

Role of gas chromatography-mass spectrometry with negative ion chemical ionization in clinical and forensic toxicology, doping control, and biomonitoringMAURER, Hans H.Therapeutic drug monitoring. 2002, Vol 24, Num 2, pp 247-254, issn 0163-4356Article

Toxicokinetics of amphetamines: Metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivativesKRAEMER, Thomas; MAURER, Hans H.Therapeutic drug monitoring. 2002, Vol 24, Num 2, pp 277-289, issn 0163-4356Article

Metabolism and toxicological detection of the new designer drug 3', 4'-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometrySPRINGER, Dietmar; FRITSCHI, Giselher; MAURER, Hans H et al.Journal of chromatography. B. 2003, Vol 793, Num 2, pp 377-388, issn 1570-0232, 12 p.Article

Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodoneSTAACK, Roland F; MAURER, Hans H.Journal of analytical toxicology. 2003, Vol 27, Num 8, pp 560-568, issn 0146-4760, 9 p.Article

Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometryEWALD, Andreas H; EHLERS, Dorothea; MAURER, Hans H et al.Analytical and bioanalytical chemistry. 2008, Vol 390, Num 7, pp 1837-1842, 6 p.Article

Demands on scientific studies in clinical toxicologyMAURER, Hans H.Forensic science international. 2007, Vol 165, Num 2-3, pp 194-198, issn 0379-0738, 5 p.Article

2,5-Dimethoxyamphetamine-derived designer drugs : Studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6EWALD, Andreas H; MAURER, Hans H.Toxicology letters. 2008, Vol 183, Num 1-3, pp 52-57, issn 0378-4274, 6 p.Article

New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometrySTAACK, Roland F; MAURER, Hans H.Journal of mass spectrometry. 2004, Vol 39, Num 3, pp 255-261, issn 1076-5174, 7 p.Article

Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometrySTAACK, Roland F; MAURER, Hans H.Journal of chromatography. B. 2003, Vol 798, Num 2, pp 333-342, issn 1570-0232, 10 p.Article

The antispasmodic drug mebeverine leads to positive amphetamine results by fluorescence polarization immunoassay (FPIA) : Studies on the toxicological analysis of urine by FPIA and GC-MSKRAEMER, Thomas; WENNIG, Robert; MAURER, Hans H et al.Journal of analytical toxicology. 2001, Vol 25, Num 5, pp 333-338, issn 0146-4760Conference Paper

Methods for the measurement of benzodiazepines in biological samplesDRUMMER, O. H.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 713, Num 1, pp 201-225, issn 1387-2273Article

Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP) : Involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometryEWALD, Andreas H; PUETZ, Michael; MAURER, Hans H et al.Journal of chromatography. B. 2008, Vol 862, Num 1-2, pp 252-256, issn 1570-0232, 5 p.Article

Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasmaPETERS, Frank T; MAURER, Hans H.Analytical chemistry (Washington, DC). 2007, Vol 79, Num 13, pp 4967-4976, issn 0003-2700, 10 p.Article

Toxicokinetics of drugs of abuse : Current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeineMAURER, Hans H; SAUER, Christoph; THEOBALD, Denis S et al.Therapeutic drug monitoring. 2006, Vol 28, Num 3, pp 447-453, issn 0163-4356, 7 p.Article

Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping controlMAURER, Hans H.Clinical chemistry and laboratory medicine. 2004, Vol 42, Num 11, pp 1310-1324, issn 1434-6621, 15 p.Article